Further studies are needed for different classes of drugs, starting from melatonin to HIF-prolyl hydroxylase inhibitors and SGLT2 inhibitors, to show their impact on DKD occurrence and progression by improving kidney oxygen homeostasis. Here, SLC5A2 is linked to diabetic kidney disease.